| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.879 | 0.004 | 0.879 | Aldehyde oxidase inhibitor | 0.207 0.101 CID_154699817 | ||
| 0.844 | 0.001 | 0.844 | Androgen agonist | 0.342 0.003 CID_154699817 | ||
| 0.834 | 0.002 | 0.834 | Androgen antagonist | 0.266 0.008 CID_154699817 | ||
| 0.841 | 0.01 | 0.883 | Antiinflammatory | 0.883 0.006 CID_154699817 | CID_154699817 | |
| 0.824 | 0.002 | 0.824 | Aromatase inhibitor | 0.166 0.011 CID_154699817 | ||
| 0.818 | 0.004 | 0.927 | Cholesterol antagonist | 0.927 0.002 CID_154699817 | CID_154699817 | |
| 0.8 | 0.013 | 0.916 | Transcription factor NF kappa B inhibitor | 0.916 0.005 CID_154699817 | CID_154699817 | |
| 0.788 | 0.003 | 0.788 | Anesthetic general | 0.763 0.003 CID_154699817 | ||
| 0.776 | 0.014 | 0.817 | Caspase 9 stimulant | 0.817 0.009 CID_154699817 | CID_154699817 | |
| 0.774 | 0.02 | 0.796 | Apoptosis agonist | 0.796 0.017 CID_154699817 | CID_154699817 | |
| 0.726 | 0.002 | 0.726 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.052 0.005 CID_154699817 | ||
| 0.725 | 0.004 | 0.76 | Hypoxia-inducible factor 1 alpha inhibitor | 0.76 0.004 CID_154699817 | CID_154699817 | |
| 0.713 | 0.002 | 0.713 | Estrogen receptor alpha antagonist | 0.088 0.037 CID_154699817 | ||
| 0.692 | 0.003 | 0.692 | NOS3 expression enhancer | 0.62 0.004 CID_154699817 | ||
| 0.688 | 0.004 | 0.771 | Diuretic | 0.771 0.003 CID_154699817 | CID_154699817 | |
| 0.683 | 0.003 | 0.683 | Estrogen agonist | 0.493 0.004 CID_154699817 | ||
| 0.661 | 0.001 | 0.661 | Anabolic | 0.243 0.002 CID_154699817 | ||
| 0.662 | 0.003 | 0.662 | Estrogen antagonist | 0.309 0.006 CID_154699817 | ||
| 0.615 | 0.002 | 0.615 | Lipocortins synthesis antagonist | 0.494 0.004 CID_154699817 | ||
| 0.61 | 0.001 | 0.61 | Aldosterone antagonist | 0.146 0.005 CID_154699817 | ||
| 0.584 | 0.002 | 0.584 | Estradiol 17 beta-dehydrogenase inhibitor | 0.05 0.025 CID_154699817 | ||
| 0.573 | 0.012 | 0.65 | Apoptosis antagonist | 0.65 0.005 CID_154699817 | CID_154699817 | |
| 0.575 | 0.016 | 0.63 | Immunosuppressant | 0.63 0.01 CID_154699817 | CID_154699817 | |
| 0.55 | 0.001 | 0.55 | RNA-directed RNA polymerase stimulant | 0.45 0.001 CID_154699817 | ||
| 0.551 | 0.002 | 0.551 | Progesterone antagonist | 0.042 0.021 CID_154699817 | ||
| 0.541 | 0.004 | 0.61 | Interferon gamma antagonist | 0.61 0.002 CID_154699817 | CID_154699817 | |
| 0.539 | 0.013 | 0.585 | Nitric oxide antagonist | 0.585 0.01 CID_154699817 | CID_154699817 | |
| 0.519 | 0.002 | 0.519 | Pregnane X receptor agonist | 0.138 0.079 CID_154699817 | ||
| 0.517 | 0.003 | 0.517 | Estrogen receptor beta agonist | 0.234 0.004 CID_154699817 | ||
| 0.516 | 0.002 | 0.516 | Estrogen receptor alpha agonist | 0.19 0.005 CID_154699817 | ||
| 0.517 | 0.006 | 0.542 | Interleukin 2 agonist | 0.542 0.005 CID_154699817 | CID_154699817 | |
| 0.509 | 0.004 | 0.509 | Sodium/bile acid cotransporter inhibitor | 0.427 0.011 CID_154699817 | ||
| 0.503 | 0.004 | 0.503 | Estrogen receptor beta antagonist | 0.139 0.019 CID_154699817 | ||
| 0.498 | 0.002 | 0.498 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.037 0.017 CID_154699817 | ||
| 0.502 | 0.014 | 0.502 | DNA damaging | 0.499 0.014 CID_154699817 | ||
| 0.482 | 0.009 | 0.482 | P-glycoprotein inhibitor | 0.337 0.023 CID_154699817 | ||
| 0.462 | 0.001 | 0.462 | 5-Alpha-reductase 1 inhibitor | 0.092 0.005 CID_154699817 | ||
| 0.459 | 0 | 0.459 | Transcortin receptor antagonist | 0.015 0.002 CID_154699817 | ||
| 0.451 | 0.006 | 0.451 | Adenylate cyclase inhibitor | 0.294 0.014 CID_154699817 | ||
| 0.455 | 0.012 | 0.628 | Interleukin agonist | 0.628 0.004 CID_154699817 | CID_154699817 | |
| 0.438 | 0.001 | 0.438 | 5-Alpha-reductase 2 inhibitor | 0.194 0.003 CID_154699817 | ||
| 0.431 | 0.002 | 0.431 | 5-Alpha-reductase inhibitor | 0.336 0.003 CID_154699817 | ||
| 0.416 | 0.004 | 0.416 | Cholesterol synthesis inhibitor | 0.36 0.006 CID_154699817 | ||
| 0.42 | 0.01 | 0.566 | Melanin inhibitor | 0.566 0.005 CID_154699817 | CID_154699817 | |
| 0.432 | 0.035 | 0.432 | Caspase 3 stimulant | 0.415 0.04 CID_154699817 | ||
| 0.427 | 0.03 | 0.644 | Antioxidant | 0.644 0.009 CID_154699817 | CID_154699817 | |
| 0.395 | 0.003 | 0.395 | Mineralocorticoid receptor antagonist | 0.105 0.007 CID_154699817 | ||
| 0.429 | 0.042 | 0.619 | Immunostimulant | 0.619 0.014 CID_154699817 | CID_154699817 | |
| 0.396 | 0.014 | 0.606 | Hepatoprotectant | 0.606 0.004 CID_154699817 | CID_154699817 | |
| 0.388 | 0.011 | 0.388 | Phospholipase C inhibitor | 0.193 0.049 CID_154699817 | ||
| 0.376 | 0.002 | 0.376 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.096 0.011 CID_154699817 | ||
| 0.376 | 0.004 | 0.376 | Farnesoid X receptor antagonist | 0.211 0.019 CID_154699817 | ||
| 0.377 | 0.009 | 0.377 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.263 0.037 CID_154699817 | ||
| 0.365 | 0.002 | 0.365 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.267 0.002 CID_154699817 | ||
| 0.357 | 0.007 | 0.357 | Aldehyde dehydrogenase inhibitor | 0.258 0.017 CID_154699817 | ||
| 0.375 | 0.026 | 0.761 | Angiogenesis stimulant | 0.761 0.004 CID_154699817 | CID_154699817 | |
| 0.35 | 0.003 | 0.35 | Bile acid receptor antagonist | 0.149 0.008 CID_154699817 | ||
| 0.359 | 0.012 | 0.579 | Amylase inhibitor | 0.579 0.004 CID_154699817 | CID_154699817 | |
| 0.352 | 0.009 | 0.352 | Antipruritic | 0.222 0.036 CID_154699817 | ||
| 0.367 | 0.034 | 0.464 | Tumour necrosis factor alpha release inhibitor | 0.464 0.018 CID_154699817 | CID_154699817 | |
| 0.329 | 0.001 | 0.329 | Arachidonic acid antagonist | 0.275 0.003 CID_154699817 | ||
| 0.338 | 0.011 | 0.338 | Neurotrophic factor enhancer | 0.312 0.015 CID_154699817 | ||
| 0.324 | 0.002 | 0.324 | Glucocorticoid antagonist | 0.139 0.004 CID_154699817 | ||
| 0.344 | 0.031 | 0.488 | DNA synthesis inhibitor | 0.488 0.014 CID_154699817 | CID_154699817 | |
| 0.344 | 0.034 | 0.344 | Antimitotic | |||
| 0.314 | 0.012 | 0.468 | Alkylator | 0.468 0.005 CID_154699817 | CID_154699817 | |
| 0.39 | 0.096 | 0.712 | Cyclophilin D inhibitor | 0.712 0.013 CID_154699817 | CID_154699817 | |
| 0.298 | 0.005 | 0.298 | Beta tubulin antagonist | |||
| 0.346 | 0.053 | 0.346 | Calcium channel activator | |||
| 0.306 | 0.018 | 0.419 | Lipid peroxidase inhibitor | 0.419 0.009 CID_154699817 | CID_154699817 | |
| 0.29 | 0.002 | 0.29 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.291 | 0.005 | 0.51 | AMP-activated protein kinase stimulant | 0.51 0.003 CID_154699817 | CID_154699817 | |
| 0.294 | 0.012 | 0.294 | DNA polymerase I inhibitor | 0.259 0.016 CID_154699817 | ||
| 0.319 | 0.038 | 0.34 | Psychostimulant | 0.34 0.033 CID_154699817 | CID_154699817 | |
| 0.309 | 0.031 | 0.434 | Platelet adhesion inhibitor | 0.434 0.009 CID_154699817 | CID_154699817 | |
| 0.291 | 0.017 | 0.291 | Growth factor agonist | 0.197 0.066 CID_154699817 | ||
| 0.267 | 0.005 | 0.267 | Hedgehog signaling inhibitor | 0.17 0.017 CID_154699817 | ||
| 0.324 | 0.063 | 0.362 | 5 Hydroxytryptamine release stimulant | 0.362 0.054 CID_154699817 | CID_154699817 | |
| 0.264 | 0.003 | 0.264 | Glycine receptor agonist | 0.25 0.003 CID_154699817 | ||
| 0.262 | 0.002 | 0.294 | Glycine receptor antagonist | 0.294 0.002 CID_154699817 | CID_154699817 | |
| 0.26 | 0.006 | 0.26 | Microtubule formation inhibitor | 0.258 0.007 CID_154699817 | ||
| 0.256 | 0.005 | 0.256 | Keratolytic | 0.078 0.051 CID_154699817 | ||
| 0.253 | 0.004 | 0.253 | Adenylate cyclase stimulant | 0.171 0.034 CID_154699817 | ||
| 0.277 | 0.037 | 0.277 | Growth hormone agonist | |||
| 0.263 | 0.024 | 0.263 | Tubulin antagonist | |||
| 0.26 | 0.021 | 0.306 | Interleukin 6 antagonist | 0.306 0.014 CID_154699817 | CID_154699817 | |
| 0.243 | 0.005 | 0.243 | Alpha tubulin antagonist | |||
| 0.295 | 0.059 | 0.295 | Transcription factor STAT inhibitor | |||
| 0.294 | 0.059 | 0.294 | Cardiotonic | |||
| 0.258 | 0.023 | 0.258 | Bone formation stimulant | 0.169 0.047 CID_154699817 | ||
| 0.276 | 0.052 | 0.276 | Gastrin inhibitor | 0.242 0.089 CID_154699817 | ||
| 0.226 | 0.008 | 0.226 | Interleukin 8 antagonist | 0.135 0.045 CID_154699817 | ||
| 0.26 | 0.044 | 0.26 | RNA-directed DNA polymerase inhibitor | 0.247 0.051 CID_154699817 | ||
| 0.325 | 0.117 | 0.653 | Antibacterial | 0.653 0.013 CID_154699817 | CID_154699817 | |
| 0.202 | 0.002 | 0.202 | Progesterone agonist | 0.096 0.004 CID_154699817 | ||
| 0.2 | 0.002 | 0.236 | Na+ K+ transporting ATPase inhibitor | 0.236 0.002 CID_154699817 | CID_154699817 | |
| 0.26 | 0.063 | 0.3 | Hypolipemic | 0.3 0.049 CID_154699817 | CID_154699817 | |
| 0.26 | 0.064 | 0.498 | Free radical scavenger | 0.498 0.016 CID_154699817 | CID_154699817 | |
| 0.288 | 0.103 | 0.288 | Vasodilator, peripheral | 0.218 0.156 CID_154699817 | ||
| 0.203 | 0.033 | 0.49 | Monophenol monooxygenase inhibitor | 0.49 0.008 CID_154699817 | CID_154699817 | |
| 0.17 | 0.003 | 0.17 | Estrogen-related receptor beta agonist | |||
| 0.166 | 0.003 | 0.166 | Estrone sulfatase inhibitor | 0.057 0.006 CID_154699817 | ||
| 0.202 | 0.041 | 0.303 | Protein kinase stimulant | 0.303 0.016 CID_154699817 | CID_154699817 | |
| 0.245 | 0.086 | 0.245 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.246 | 0.087 | 0.246 | Transcription factor STAT3 inhibitor | |||
| 0.266 | 0.114 | 0.618 | Antithrombotic | 0.618 0.014 CID_154699817 | CID_154699817 | |
| 0.144 | 0.002 | 0.144 | Lipocortins synthesis agonist | 0.123 0.003 CID_154699817 | ||
| 0.157 | 0.016 | 0.157 | ABCA1 expression enhancer | 0.085 0.076 CID_154699817 | ||
| 0.175 | 0.041 | 0.175 | Neurotrophic factor | 0.126 0.086 CID_154699817 | ||
| 0.126 | 0.002 | 0.126 | Pregnane X receptor antagonist | 0.067 0.018 CID_154699817 | ||
| 0.146 | 0.023 | 0.177 | Toll-Like receptor 4 antagonist | 0.177 0.01 CID_154699817 | CID_154699817 | |
| 0.124 | 0.002 | 0.124 | Glucocorticoid agonist | 0.055 0.004 CID_154699817 | ||
| 0.125 | 0.005 | 0.125 | Liver X receptor alpha agonist | |||
| 0.153 | 0.036 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.15 0.042 CID_154699817 | ||
| 0.14 | 0.027 | 0.14 | Prolactin inhibitor | |||
| 0.144 | 0.032 | 0.26 | Antineoplastic antibiotic | 0.26 0.013 CID_154699817 | CID_154699817 | |
| 0.114 | 0.003 | 0.114 | Adenylate cyclase 1 inhibitor | |||
| 0.113 | 0.003 | 0.113 | Glucose-6-phosphate dehydrogenase inhibitor | 0.067 0.005 CID_154699817 | ||
| 0.134 | 0.025 | 0.134 | Acetylcholine nicotinic antagonist | |||
| 0.152 | 0.047 | 0.28 | Cyclooxygenase 3 inhibitor | 0.28 0.007 CID_154699817 | CID_154699817 | |
| 0.126 | 0.022 | 0.126 | Ornithine decarboxylase inhibitor | 0.099 0.045 CID_154699817 | ||
| 0.126 | 0.022 | 0.126 | Inducible nitric-oxide synthase inhibitor | |||
| 0.205 | 0.107 | 0.579 | Hypoglycemic | 0.579 0.009 CID_154699817 | CID_154699817 | |
| 0.116 | 0.02 | 0.116 | CDC25A inhibitor | 0.067 0.063 CID_154699817 | ||
| 0.097 | 0.002 | 0.097 | Corticosteroid-like | 0.064 0.003 CID_154699817 | ||
| 0.1 | 0.007 | 0.1 | Heme oxygenase stimulant | 0.078 0.017 CID_154699817 | ||
| 0.126 | 0.035 | 0.126 | Antineoplastic alkaloid | |||
| 0.117 | 0.027 | 0.169 | Transcription factor NF kappa B stimulant | 0.169 0.013 CID_154699817 | CID_154699817 | |
| 0.245 | 0.161 | 0.245 | Antiobesity | |||
| 0.093 | 0.009 | 0.093 | Potassium channel Kv1.3 blocker | |||
| 0.085 | 0.005 | 0.085 | Farnesoid X receptor agonist | |||
| 0.14 | 0.061 | 0.161 | Alpha-N-acetylglucosaminidase inhibitor | 0.161 0.049 CID_154699817 | CID_154699817 | |
| 0.134 | 0.057 | 0.134 | Anesthetic local | |||
| 0.113 | 0.038 | 0.113 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.222 | 0.146 | 0.278 | Angiogenesis inhibitor | 0.278 0.104 CID_154699817 | CID_154699817 | |
| 0.155 | 0.082 | 0.155 | Sigma receptor agonist | |||
| 0.078 | 0.011 | 0.078 | Liver X receptor agonist | |||
| 0.071 | 0.006 | 0.071 | Microtubule stabilization | 0.061 0.013 CID_154699817 | ||
| 0.147 | 0.082 | 0.147 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.081 | 0.015 | 0.081 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.066 | 0.002 | 0.066 | Hedgehog signaling activator | |||
| 0.122 | 0.062 | 0.138 | Protein-tyrosine phosphatase 1B inhibitor | 0.138 0.051 CID_154699817 | CID_154699817 | |
| 0.11 | 0.051 | 0.181 | UDP-glucose 4-epimerase inhibitor | 0.181 0.021 CID_154699817 | CID_154699817 | |
| 0.106 | 0.053 | 0.106 | Creatine kinase inhibitor | |||
| 0.097 | 0.047 | 0.123 | Glutamate release inhibitor | 0.123 0.02 CID_154699817 | CID_154699817 | |
| 0.205 | 0.158 | 0.418 | Immunomodulator | 0.418 0.039 CID_154699817 | CID_154699817 | |
| 0.098 | 0.055 | 0.098 | Alcohol dehydrogenase inhibitor | 0.086 0.07 CID_154699817 | ||
| 0.117 | 0.076 | 0.117 | Cholinergic antagonist | |||
| 0.047 | 0.006 | 0.047 | Estrogen-related receptor beta antagonist | |||
| 0.115 | 0.075 | 0.115 | Acetylcholine antagonist | |||
| 0.069 | 0.03 | 0.069 | Alcohol oxidase inhibitor | |||
| 0.071 | 0.032 | 0.08 | Nitric oxide donor | 0.08 0.022 CID_154699817 | CID_154699817 | |
| 0.04 | 0.002 | 0.05 | Telomerase stimulant | 0.05 0.001 CID_154699817 | CID_154699817 | |
| 0.103 | 0.065 | 0.25 | Expectorant | 0.25 0.013 CID_154699817 | CID_154699817 | |
| 0.105 | 0.071 | 0.107 | Mucolytic | 0.107 0.068 CID_154699817 | CID_154699817 | |
| 0.101 | 0.067 | 0.169 | Beta glucuronidase inhibitor | 0.169 0.018 CID_154699817 | CID_154699817 | |
| 0.106 | 0.073 | 0.13 | Acetylcholine release stimulant | 0.13 0.034 CID_154699817 | CID_154699817 | |
| 0.044 | 0.011 | 0.044 | Tubulin agonist | |||
| 0.062 | 0.03 | 0.062 | GABA receptor antagonist | |||
| 0.05 | 0.022 | 0.05 | Parathyroid hormone antagonist | |||
| 0.029 | 0.002 | 0.029 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.004 CID_154699817 | ||
| 0.031 | 0.005 | 0.033 | Ileal bile acid transport inhibitor | 0.033 0.004 CID_154699817 | CID_154699817 | |
| 0.028 | 0.003 | 0.028 | Progesterone receptor A antagonist | |||
| 0.134 | 0.109 | 0.134 | CF transmembrane conductance regulator agonist | |||
| 0.065 | 0.04 | 0.065 | Calcium channel P-type blocker | |||
| 0.042 | 0.018 | 0.042 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | |||
| 0.039 | 0.016 | 0.039 | HMG CoA reductase inhibitor | |||
| 0.04 | 0.017 | 0.04 | Ceramide glucosyltransferase inhibitor | |||
| 0.029 | 0.008 | 0.029 | Vitamin D receptor antagonist | 0.024 0.011 CID_154699817 | ||
| 0.053 | 0.037 | 0.053 | GABA A receptor antagonist | |||
| 0.022 | 0.006 | 0.022 | Vitamin D receptor agonist | 0.016 0.011 CID_154699817 | ||
| 0.048 | 0.032 | 0.048 | Adenosine deaminase inhibitor | |||
| 0.156 | 0.142 | 0.263 | Cyclic AMP phosphodiesterase inhibitor | 0.263 0.057 CID_154699817 | CID_154699817 | |
| 0.022 | 0.01 | 0.022 | Progesterone receptor B antagonist | |||
| 0.102 | 0.09 | 0.102 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.122 | 0.111 | 0.136 | Protein-tyrosine phosphatase inhibitor | 0.136 0.095 CID_154699817 | CID_154699817 | |
| 0.064 | 0.054 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.032 | 0.023 | 0.032 | Estrogen-related receptor alpha antagonist | |||
| 0.031 | 0.024 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.053 | 0.048 | 0.053 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.082 | 0.078 | 0.082 | Breast cancer-resistant protein inhibitor | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.021 | 0.018 | 0.021 | CYP24 inhibitor | |||
| 0.073 | 0.071 | 0.073 | Opioid kappa receptor antagonist | |||
| 0.052 | 0.051 | 0.052 | Botulinum neurotoxin type A inhibitor | |||
| 0.035 | 0.034 | 0.035 | GABA uptake inhibitor | |||
| 0.116 | 0.118 | 0.248 | Insulin secretagoues | 0.248 0.02 CID_154699817 | CID_154699817 | |
| 0.119 | 0.123 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.024 CID_154699817 | CID_154699817 | |
| 0.042 | 0.047 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 CID_154699817 | CID_154699817 | |
| 0.094 | 0.102 | 0.125 | Photosensitizer | 0.125 0.051 CID_154699817 | CID_154699817 | |
| 0.046 | 0.054 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.017 CID_154699817 | CID_154699817 | |
| 0.103 | 0.113 | 0.136 | Interleukin 4 antagonist | 0.136 0.064 CID_154699817 | CID_154699817 | |
| 0.041 | 0.052 | 0.115 | Protein 50S ribosomal subunit inhibitor | 0.115 0.01 CID_154699817 | CID_154699817 | |
| 0.052 | 0.066 | 0.117 | Phosphofructokinase-1 inhibitor | 0.117 0.026 CID_154699817 | CID_154699817 | |
| 0.158 | 0.172 | 0.381 | Peptidyltransferase inhibitor | 0.381 0.008 CID_154699817 | CID_154699817 | |
| 0.074 | 0.089 | 0.104 | NADH dehydrogenase inhibitor | 0.104 0.04 CID_154699817 | CID_154699817 | |
| 0.02 | 0.037 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 CID_154699817 | CID_154699817 | |
| 0.072 | 0.093 | 0.1 | Triose-phosphate isomerase inhibitor | 0.1 0.048 CID_154699817 | CID_154699817 | |
| 0.022 | 0.044 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_154699817 | CID_154699817 | |
| 0.146 | 0.169 | 0.181 | Spasmolytic | 0.181 0.136 CID_154699817 | CID_154699817 | |
| 0.016 | 0.04 | 0.061 | Protein 30S ribosomal subunit inhibitor | 0.061 0.006 CID_154699817 | CID_154699817 | |
| 0.128 | 0.156 | 0.236 | Non-steroidal antiinflammatory agent | 0.236 0.049 CID_154699817 | CID_154699817 | |
| 0.003 | 0.035 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 CID_154699817 | CID_154699817 | |
| 0.013 | 0.049 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 CID_154699817 | CID_154699817 | |
| 0.107 | 0.146 | 0.368 | Hemostatic | 0.368 0.01 CID_154699817 | CID_154699817 | |
| 0.028 | 0.07 | 0.056 | Mannosidase inhibitor | 0.056 0.019 CID_154699817 | CID_154699817 | |
| 0.025 | 0.07 | 0.074 | Antibiotic Aminoglycoside-like | 0.074 0.005 CID_154699817 | CID_154699817 | |
| 0.038 | 0.086 | 0.1 | Heparanase inhibitor | 0.1 0.004 CID_154699817 | CID_154699817 | |
| 0.012 | 0.074 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.015 CID_154699817 | CID_154699817 | |
| 0.129 | 0.191 | 0.261 | Vasodilator | 0.261 0.063 CID_154699817 | CID_154699817 | |
| 0.045 | 0.114 | 0.17 | Topoisomerase II alpha inhibitor | 0.17 0.02 CID_154699817 | CID_154699817 | |
| 0.158 | 0.228 | 0.281 | Vasodilator, coronary | 0.281 0.104 CID_154699817 | CID_154699817 | |
| 0.057 | 0.126 | 0.2 | Topoisomerase I inhibitor | 0.2 0.026 CID_154699817 | CID_154699817 | |
| 0.013 | 0.089 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 CID_154699817 | CID_154699817 | |
| 0.091 | 0.18 | 0.174 | Hexokinase inhibitor | 0.174 0.054 CID_154699817 | CID_154699817 | |
| 0.067 | 0.161 | 0.166 | Multidrug resistance-associated protein 1 inhibitor | 0.166 0.019 CID_154699817 | CID_154699817 | |
| 0.156 | 0.273 | 0.424 | Histamine release inhibitor | 0.424 0.063 CID_154699817 | CID_154699817 | |
| 0.051 | 0.172 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.098 0.043 CID_154699817 | CID_154699817 | |
| 0.029 | 0.162 | 0.066 | Neuraminidase (influenza) inhibitor | 0.066 0.041 CID_154699817 | CID_154699817 | |
| 0.052 | 0.195 | 0.081 | Thioredoxin inhibitor | 0.081 0.08 CID_154699817 | CID_154699817 | |
| 0.1 | 0.246 | 0.19 | ATPase inhibitor | 0.19 0.046 CID_154699817 | CID_154699817 | |
| 0.059 | 0.207 | 0.275 | Thrombolytic | 0.275 0.028 CID_154699817 | CID_154699817 | |
| 0.062 | 0.233 | 0.317 | Cell adhesion inhibitor | 0.317 0.009 CID_154699817 | CID_154699817 | |
| 0.019 | 0.198 | 0.302 | Selectin antagonist | 0.302 0.005 CID_154699817 | CID_154699817 | |
| 0.015 | 0.196 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_154699817 | CID_154699817 | |
| 0.024 | 0.205 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 CID_154699817 | CID_154699817 | |
| 0.038 | 0.23 | 0.206 | Topoisomerase II inhibitor | 0.206 0.032 CID_154699817 | CID_154699817 | |
| 0.059 | 0.281 | 0.166 | Cell wall synthesis inhibitor | 0.166 0.051 CID_154699817 | CID_154699817 | |
| 0.031 | 0.257 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.039 CID_154699817 | CID_154699817 | |
| 0.023 | 0.361 | 0.113 | DNA intercalator | 0.113 0.062 CID_154699817 | CID_154699817 | |
| 0.04 | 0.416 | 0.217 | Platelet antagonist | 0.217 0.09 CID_154699817 | CID_154699817 | |
| 0.05 | 0.441 | 0.111 | DNA repair enzyme inhibitor | 0.111 0.094 CID_154699817 | CID_154699817 | |
| 0.005 | 0.859 | 0.131 | Anticoagulant | 0.131 0.098 CID_154699817 | CID_154699817 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |